Antibodies on one side of the BiTE bind specifically to tumor cell surface tumor antigens, such as PSMA, generating activation signals delivered to the T cell CD3 surface receptors via antibodies on the other side (86). The gene discussed is FOLH1; the disease is neoplasm.